Get the Stockscreener App
8.47
1.17%
-0.10
After Hours:
8.33
-0.14
-1.65%
Alpha Cognition Inc stock is traded at $8.47, with a volume of 115.14K.
It is down -1.17% in the last 24 hours and down -13.13% over the past month.
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
See More
Previous Close:
$8.57
Open:
$8.49
24h Volume:
115.14K
Relative Volume:
0.97
Market Cap:
$184.46M
Revenue:
$10.83M
Net Income/Loss:
$-25.14M
P/E Ratio:
-6.1717
EPS:
-1.3724
Net Cash Flow:
$-30.41M
1W Performance:
-4.08%
1M Performance:
-13.13%
6M Performance:
+59.21%
1Y Performance:
+9.72%
1-Day Range:
$8.30
$8.695
1-Week Range:
$8.30
$9.205
52-Week Range:
$4.50
$10.14
Alpha Cognition Inc Stock (ACOG) Company Profile
Name
Alpha Cognition Inc
Sector
Industry
Phone
(858) 344-4375
Address
1452 HUGHES RD., STE. 200, GRAPEVINE
Compare ACOG vs VRTX, REGN, MRNA, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACOG
Alpha Cognition Inc
|
8.47 | 184.46M | 10.83M | -25.14M | -30.41M | -1.3724 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Alpha Cognition Inc Stock (ACOG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-26 | Initiated | Craig Hallum | Buy |
| Mar-18-25 | Initiated | H.C. Wainwright | Buy |
Alpha Cognition Inc Stock (ACOG) Latest News
Can Alpha (ACOG) Sustain Its +5.36% Momentum This Week? 2026-09-17Bullish Pattern Stocks - careplusvn.com
Alpha Cognition (ACOG) 10% holder adds 123,918 shares near $8.40–$8.72 - Stock Titan
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)September 9, 2026 - BioSpace
Alpha Cognition grants new employee 25,000 inducement stock options at USD 9.52 strike price - Bitget
Alpha Cognition Inc. (ACOG) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Eastern Progress
Alpha Cognition (ACOG) Up 2.39% to $9.43: Biotech Climbs Toward $9.90 ResistanceSector Neutral Pair - siam.in
Alpha Cognition (ACOG) director adds 10,000 shares - Stock Titan
Alpha Cognition Inc. Revenue Breakdown – NASDAQ:ACOG - TradingView
Alpha Cognition (NASDAQ:ACOG) Raised to "Strong-Buy" at B. Riley Financial - MarketBeat
Alpha (ACOG) Earnings Update: The Available Figures Are Largely in Line on the Day; Trading Response - vinanet.vn
Alpha Cognition stock wins Buy at B. Riley (ACOG:NASDAQ) - Seeking Alpha
B. Riley Initiates Alpha Cognition at Buy With $21 Price Target - marketscreener.com
B.Riley initiates Alpha Cognition stock with buy, $21 price target - Investing.com India
Alpha Cognition Inc. (NASDAQ:ACOG) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Alpha (ACOG) Q2 2026 Results: Available Metrics Are Broadly in Line; After Results: The Stock Gains 3.67%Pre-Earnings Drift - vinanet.vn
Alpha (ACOG) Results Review: The Available Figures Are Largely in Line; Market Response: The Share Price Adds 6.12% for the Current SessionRevenue Guidance Range - vinanet.vn
Q3 EPS Estimates for Alpha Cognition Decreased by Analyst - MarketBeat
H.C. Wainwright Maintains Alpha Cognition(ACOG.US) With Buy Rating, Maintains Target Price $20 - Moomoo
H.C. Wainwright raises Alpha Cognition stock price target to $20 By Investing.com - Investing.com South Africa
Q4 EPS Estimates for Alpha Cognition Increased by Analyst - MarketBeat
H.C. Wainwright raises Alpha Cognition stock price target to $20 - Investing.com
Analysts Conflicted on These Healthcare Names: Alpha Cognition Inc (ACOG) and TScan Therapeutics (TCRX) - The Globe and Mail
Alpha Cognition's Q2 revenue jumps 259%, prompting a 127% price target hike to $20. - Pluang
ACOG Q2 2026 Earnings: Clinical-Stage Net Loss of $0.40 Per Share Slightly Misses ConsensusGuidance Upgrade Report - vinanet.vn
symbol__ Stock Quote Price and Forecast - CNN
ACOG Maintained by HC Wainwright & Co. -- Price Target Raised to $20.00 - GuruFocus
HC Wainwright Forecasts Strong Price Appreciation for Alpha Cognition (NASDAQ:ACOG) Stock - MarketBeat
Alpha Cognition price target raised to $20 from $18 at H.C. Wainwright - TipRanks
Alpha Cognition's Q2 revenue jumps 71% as ZUNVE... - Pluang
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) 2Q26 - Yahoo Finance
Alpha Cognition (ACOG) Stock Fair Value Rises After Zunveyl Analyst Optimism - Yahoo Finance
Alpha Cognition (ACOG) Gains 2.43% to $8.84, Approaching Key Resistance at $9.28Value Factor - vinanet.vn
Alpha Cognition reports Q2 EPS (40c), consensus (39c) - TipRanks
Alpha Cognition price target raised to $17 from $14 at Craig-Hallum - TipRanks
Alpha Cognition Maintained at Buy as Strong Zunveyl-Driven Growth and Solid Cash Position Support Unchanged $12 Price Target - TipRanks
Teleconferência de Resultados do 2º Trimestre de 2026 da Alpha Cognition (ACOG): Vendas do ZUNVEYL Subem 71% - TradingKey
Alpha Cognition (NASDAQ:ACOG) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Alpha Cognition Inc. Common Stock Q2 2026 Earnings Call Summary - Yahoo Finance
Why is Alpha Cognition stock surging today? By Investing.com - Investing.com Canada
Alpha Cognition reports Q2 revenue growth, narrows loss By Investing.com - Investing.com Australia
Alpha Cognition Q2 Revenue Surges 270% to $6.09 Million - Minichart
ACOG Q2 2026 Earnings: Clinical Pipeline Progress in Focus as Loss Per Share Slightly Misses Estimates - dars.gov.et
Alpha Cognition Inc. Reports Second Quarter 2026 Financial Results and Provides Operational Update - biospace.com
Alpha Cognition (ACOG) Q2 2026 Earnings Call Transcript - AOL.com
Alpha Cognition (NASDAQ:ACOG) Announces Quarterly Earnings Results - MarketBeat
Earnings call transcript: Alpha Cognition posts strong Q2 2026 sales growth - Investing.com Canada
Alpha Cognition Inc. (ACOG) Reports Q2 Loss, Tops Revenue Estimates - sharewise.com
ACOG: ZUNVEYL achieved 71% sequential revenue growth in Q2 2026, driven by strong long-term care adoption - TradingView
Alpha Cognition Q2 Earnings Call Highlights - MarketBeat
Alpha Cognition Q2 sales beat estimates, EPS misses consensus - scanx.trade
Alpha Cognition Q2 2026 Earnings Call Transcript - Benzinga
Alpha Cognition Inc Stock (ACOG) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.06%
2.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):